Reciprocal relationship between methylation status and loss of heterozygosity at the p14ARF locus in Australian and South African hepatocellular carcinomas

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 3, 2002, Pages 301-307

  Herath, Nirmitha I ^a,d   Kew, Michael C ^c   Walsh, Michael D ^c   Young, Joanne ^a   Powell, Lawrie W ^b   Leggett, Barbara A ^a   Macdonald, Graeme A ^b  

^a Clinical Research Center   (South Africa)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d Royal Brisbane and Womens Hospital Research Foundation   (Australia)

Author keywords

Hepatocellular carcinoma; Loss of heterozygosity; p14; p16; Promoter methylation

Indexed keywords

PROTEIN P14; PROTEIN P16; PROTEIN P53;

ADULT; AGED; ARTICLE; AUSTRALIA; CHROMOSOME 9P; CONTROLLED STUDY; EXON; FEMALE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METHYLATION; MOLECULAR BIOLOGY; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOUTH AFRICA; TUMOR SUPPRESSOR GENE;

EID: 0036097044     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02704.x     Document Type: Article

References (25)

1. NIH conference. Hepatocellular carcinoma
2. Estimates of the worldwide frequency of twelve major cancers
3. Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population
4. p16 (INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma
5. High frequency of p16INK4A gene alterations in hepatocellular carcinoma
6. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53
7. Mutations and altered expression of p16INK4 in human cancer
8. The INK4A/ARF locus and its two gene products
9. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
10. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
11. Hypermethylation-associated inactivation of p14 (ARF) is independent of p16 (INK4a) methylation and p53 mutational status
12. Alterations and hypermethylation of the p14 (ARF) gene in gastric cancer
13. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype
14. A simple salting out procedure for extracting DNA from human nucleated cells
15. Analysis of the INK4a/ARF locus in non-Hodgkin's lymphomas using two new internal microsatellite markers
16. An Alu polymorphism intragenic to the TP53 gene
17. Polymerase chain reaction detection of a highly polymorphic VNTR segment in intron 1 of the human p53 gene
18. Germline p16 mutations in familial melanoma
19. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
20. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
21. Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer
22. The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer
23. Tumour suppression at the mouse INK4a locus mediated by the alternate reading frame product p19ARF
24. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis-a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma
25. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa